MaxCyte, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma (NCT03608618) | MaxCyte, Inc. | 2018-08-27 |
Track MaxCyte, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.